BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3585142)

  • 1. Enhancement of macrophage and monocyte cytotoxicity by the surface active material of lung lining fluid.
    Baughman RP; Mangels DJ; Strohofer S; Corser BC
    J Lab Clin Med; 1987 Jun; 109(6):692-7. PubMed ID: 3585142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung derived surface active material (SAM) inhibits natural killer cell tumor cytotoxicity.
    Baughman RP; Strohofer S
    J Clin Lab Immunol; 1989 Feb; 28(2):51-4. PubMed ID: 2787406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of in vitro tumoricidal activity in alveolar macrophages and monocytes from patients with lung cancer.
    Thomassen MJ; Wiedemann HP; Barna BP; Farmer M; Ahmad M
    Cancer Res; 1988 Jul; 48(14):3949-53. PubMed ID: 2838166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic activity of human pulmonary alveolar macrophages.
    Kan-Mitchell J; Hengst JC; Kempf RA; Rothbart RK; Simons SM; Brooker AS; Kortes VL; Mitchell MS
    Cancer Res; 1985 Jan; 45(1):453-8. PubMed ID: 3965151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous tumor cell killing by human blood monocytes and human peritoneal macrophages: lack of alteration by endotoxin or quenchers of reactive oxygen species.
    Weinberg JB; Haney AF
    J Natl Cancer Inst; 1983 Jun; 70(6):1005-10. PubMed ID: 6574267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of human alveolar macrophage tumoricidal activity by C-reactive protein.
    Barna BP; Thomassen MJ; Wiedemann HP; Ahmad M; Deodhar SD
    J Biol Response Mod; 1988 Oct; 7(5):483-7. PubMed ID: 3183685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alveolar macrophage and blood monocyte function in lung cancer.
    Hosker HS; Corris PA
    Cancer Detect Prev; 1991; 15(2):103-6. PubMed ID: 2032250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.
    Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG
    J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effector cell function at different stages of human monocyte-macrophage maturation.
    Andreesen R; Osterholz J; Bross KJ; Schulz A; Luckenbach GA; Löhr GW
    Cancer Res; 1983 Dec; 43(12 Pt 1):5931-6. PubMed ID: 6357433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human alveolar macrophages: wheat germ agglutinin-dependent tumor cell killing.
    Ogawara M; Sone S; Ogura T
    Jpn J Cancer Res; 1987 Mar; 78(3):288-95. PubMed ID: 3106285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of natural killer activity by human bronchoalveolar macrophages.
    Bordignon C; Villa F; Allavena P; Introna M; Biondi A; Avallone R; Mantovani A
    J Immunol; 1982 Aug; 129(2):587-91. PubMed ID: 6177770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.
    Onozaki K; Matsushima K; Kleinerman ES; Saito T; Oppenheim JJ
    J Immunol; 1985 Jul; 135(1):314-20. PubMed ID: 3873493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human peripheral blood monocyte and bronchoalveolar macrophage cytotoxicity for cultured human lung tumor cells.
    Swinburne S; Cole P
    J Reticuloendothel Soc; 1982 Nov; 32(5):371-85. PubMed ID: 6761437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic studies of alveolar macrophages from patients with metastatic renal cell carcinoma.
    Thomassen MJ; Barna BP; Wiedemann HP; Bukowski RM; Farmer M; Ahmad M
    Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1256-8. PubMed ID: 2339845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
    Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent cellular cytotoxicity in blood monocytes and alveolar macrophages in patients with lung cancer.
    McLennan G; Gill PG; De Young NJ
    J Natl Cancer Inst; 1985 Jul; 75(1):23-7. PubMed ID: 3859693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin selectively enhances monocyte-macrophage-mediated tumoricidal activity.
    Perri RT; Vercellotti G; McCarthy J; Vessella RL; Furcht LT
    J Lab Clin Med; 1985 Jan; 105(1):30-5. PubMed ID: 3968463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alveolar macrophages in tumor-bearing rats: tumoricidal properties of carrageenan-activated macrophages.
    Bijma AM; Stehmann TE; Weijma IM; Kort WJ
    Invasion Metastasis; 1988; 8(6):364-73. PubMed ID: 3225148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites.
    Mantovani A; Bar Shavit Z; Peri G; Polentarutti N; Bordignon C; Sessa C; Mangioni C
    Clin Exp Immunol; 1980 Mar; 39(3):776-84. PubMed ID: 6155233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.